Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • GLP-1s for Medicare
  • Drug Control Strategy
  • Misoprostol
  • AI Deepfakes
  • Fruit-Flavored Vapes

WHAT'S NEW

  • GLP-1s for Medicare
  • Drug Control Strategy
  • Misoprostol
  • AI Deepfakes
  • Fruit-Flavored Vapes

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, May 21 2019

Full Issue

New Restrictive Opioid Guidelines Led To Serious Withdrawal Symptoms, Suicide For Some Chronic Pain Patients

Federal agencies have since issued warnings that the guidance has been taken too far in some cases and that providers should be careful from completely cutting off patients' medication. Other news on the crisis comes out of Tennessee and Minnesota.

Stateline: Rapid Opioid Cutoff Is Risky Too, Feds Warn 

To stem the opioid epidemic, U.S. doctors cut prescriptions of medications such as OxyContin, Vicodin and Percocet by at least a quarter over the last five years. But the reduction in prescriptions came at a cost to some pain patients. The U.S. Centers for Disease Control and Prevention and the Food and Drug Administration last month warned prescribers that abruptly cutting off high-dose patients or tapering their doses too rapidly could cause withdrawal and even suicide. (Vestal, 5/21)

Nashville Tennessean: Tennessee Doctor, Accused Of Drug Dealing, Ordered To Stop Seeing Patients

A Middle Tennessee doctor who stands accused of drug dealing at a pill mill that once overflowed with patients has been ordered by a Nashville judge to stop practicing medicine altogether. Dr. Samson Orusa, who owns a clinic in Clarksville, is now forbidden from seeing patients, writing prescriptions or supervising any nurse practitioners or other medical professionals, according to a court order from Davidson County Chancellor Ellen Hobbs Lyle. (Kelman, 5/20)

Minnesota Public Radio: Opioid Deal Puts Drugmakers On Hook For Problems

That money — included in a bill passed with overwhelming support before the Legislature adjourned Monday night — will come from substantially higher licensing fees on companies in the prescription painkiller business. Some big manufacturers will have to pay $305,000 annually to operate in Minnesota. The fees are expected to generate $20 million each year, which will go into a dedicated fund that can be used solely for opioid-related response programs. (Bakst, 5/20)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Wednesday, May 6
  • Tuesday, May 5
  • Monday, May 4
  • Friday, May 1
  • Thursday, April 30
  • Wednesday, April 29
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF